cardiket retard 120
merus labs luxco ii s.á r.l., luxembursko - izosorbiddinitrát - 83 - vasodilatantia
cardiket retard 40
merus labs luxco ii s.á r.l., luxembursko - izosorbiddinitrát - 83 - vasodilatantia
isoket
merus labs luxco ii s.á r.l., luxembursko - izosorbiddinitrát - 83 - vasodilatantia
ludiomil 25
amdipharm limited, Írsko - maprotilín - 30 - antidepressiva
ludiomil 75
amdipharm limited, Írsko - maprotilín - 30 - antidepressiva
mono mack depot
pfizer europe ma eeig, belgicko - izosorbidmononitrát - 83 - vasodilatantia
klaritromycin mylan 500 mg
mylan ireland limited, Írsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
lorviqua
pfizer europe ma eeig - lorlatinib - karcinóm, pľúc bez malých buniek - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
clarithromycin hameln 500 mg prášok na koncentrát na infúzny roztok
hameln pharma gmbh, nemecko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
scemblix
novartis europharm limited - asciminib hydrochloride - leukémia, myelogénna, chronická, bcr-abl pozitívna - antineoplastické činidlá - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.